These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 2383776)

  • 1. [A heparin-like anticoagulant in a patient with Wegener's granulomatosis].
    Chrobák L; Rozsíval V; Herout V
    Bratisl Lek Listy; 1990 May; 91(5):396-8. PubMed ID: 2383776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin-like anticoagulant associated with multiple myeloma and neutralized with protamine sulfate.
    Torjemane L; Guermazi S; Ladeb S; Ben Romdhane N; Lakhal A; Abdelkefi A; Ben Othman T; Ben Abdelhadhim A
    Blood Coagul Fibrinolysis; 2007 Apr; 18(3):279-81. PubMed ID: 17413766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin-like anticoagulant associated with plasma cell myeloma.
    Chapman GS; George CB; Danley DL
    Am J Clin Pathol; 1985 Jun; 83(6):764-6. PubMed ID: 3923825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacological profile of the low molecular weight heparin 21-23 in man: anticoagulant, lipolytic and protamine reversible effects.
    Harenberg J; Stehle G; Dempfle CE; von Hodenberg E; Heene DL
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(6):967-80. PubMed ID: 2483715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Wegener's granulomatosis with anti-neutrophil cytoplasmic antibodies against anti-cathepsin G antigen].
    Ocaña Pérez E; Peña Casas AM; del Campo Muñoz T; Avila Casas A; Luque Barona R
    An Pediatr (Barc); 2013 Dec; 79(6):381-4. PubMed ID: 23602835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of blood coagulation and endothelial dysfunction in patients with Wegener's granulomatosis and related disorders.
    Egbring R; Seitz R; Andrassy K
    APMIS Suppl; 1990; 19():42-3. PubMed ID: 2285538
    [No Abstract]   [Full Text] [Related]  

  • 7. A heparin-like anticoagulant in an 8-month-old boy with acute monoblastic leukemia.
    Bussel JB; Steinherz PG; Miller DR; Hilgartner MW
    Am J Hematol; 1984 Jan; 16(1):83-90. PubMed ID: 6582779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The administration of anticoagulants.
    MARPLE CD
    Calif Med; 1950 Aug; 73(2):166-70. PubMed ID: 15426992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (Fragmin) at the site of activation of the coagulation system in man.
    Wolzt M; Weltermann A; Nieszpaur-Los M; Schneider B; Fassolt A; Lechner K; Eichler HG; Kyrle PA
    Thromb Haemost; 1995 Mar; 73(3):439-43. PubMed ID: 7667826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic study of Wegener's granulomatosis with special emphasis on early lesions in 10 Korean patients.
    Park YB; Kim JY; Linton JA; Jung HJ; Lee SK; Shin DH
    Yonsei Med J; 2001 Feb; 42(1):46-54. PubMed ID: 11293501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Images Dx. Wegener's granulomatosis.
    Alkhatib AA; Elkhatib FA; Khatib OF
    J Hosp Med; 2010; 5(5):E9. PubMed ID: 20533586
    [No Abstract]   [Full Text] [Related]  

  • 12. Circulating heparan sulfate anticoagulant in a patient with a fatal bleeding disorder.
    Palmer RN; Rick ME; Rick PD; Zeller JA; Gralnick HR
    N Engl J Med; 1984 Jun; 310(26):1696-9. PubMed ID: 6233489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.
    Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Kater K; Goodnough LT; Santoro SA; Spitznagel E; Rosenblum M; Lappas DG
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):46-54. PubMed ID: 7609568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of rivaroxaban, in contrast to heparin, is similar in neonatal and adult plasma.
    Novak M; Schlagenhauf A; Bernhard H; Schweintzger S; Leschnik B; Muntean W
    Blood Coagul Fibrinolysis; 2011 Oct; 22(7):588-92. PubMed ID: 21799400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wegener's granulomatosis is associated with organ-specific antiendothelial cell antibodies.
    Holmén C; Christensson M; Pettersson E; Bratt J; Stjärne P; Karrar A; Sumitran-Holgersson S
    Kidney Int; 2004 Sep; 66(3):1049-60. PubMed ID: 15327398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulant activity in cell-free peritoneal fluid of an experimental pancreatic ascites tumor.
    Ts'ao C; Galluzzo TS; Hart SJ; Ng AS; Sorenson PG; Subbarao V
    Thromb Haemost; 1985 Dec; 54(4):768-72. PubMed ID: 3003955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fucosylated chondroitin sulfate as a new oral antithrombotic agent.
    Fonseca RJ; Mourão PA
    Thromb Haemost; 2006 Dec; 96(6):822-9. PubMed ID: 17139379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative neutralization of the biological actions of sulfaminoheparosans (K5 derivatives) and heparins by protamine sulfate.
    Maddineni J; Hoppensteadt DA; Cornelli U; Manoni M; Fareed J
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):52-64. PubMed ID: 17164496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Wegener's granulomatosis--diagnostic problem].
    Durko T; Lapienis M; Jankowski A
    Otolaryngol Pol; 2006; 60(3):355-62. PubMed ID: 16989448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A circulating anticoagulant in lepromatous leprosy.
    Cole FS; Brusch JL; Talarico L
    Int J Lepr Other Mycobact Dis; 1979 Jun; 47(2):121-5. PubMed ID: 378869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.